Contact the Desk

Editorial correspondence

This desk welcomes notes on the record itself: a citation that's stale, a newly published study on any of the seven compounds tracked here, or a passage that overstates what a source actually found. The most useful messages name three things, which page, the passage in question, and the study or reference it should be checked against, a DOI or PubMed ID if you have one. That's enough to verify a correction before the page is updated.

Editorial mailbox: editors@bigfootpeptides.com

What this desk can't do

Because bigfootpeptides reports on published research rather than practicing medicine or selling anything, a few requests fall outside what this desk can answer. It can't weigh in on or advise human use of BPC-157, TB-500, GHK-Cu, KPV, or any of the three blends; it can't name a dose, schedule, or route for any individual; and it can't help source, verify, or recommend a supplier for any compound. None of the peptides covered here are approved medicines, and several are prohibited in competitive sport, anyone with a medical question should bring it to a licensed clinician, and anyone subject to anti-doping testing should check the current WADA Prohibited List directly. Replies aren't guaranteed and the mailbox is checked periodically.